Tuesday, April 15, 2025
Largest Genome-Wide Association Study Uncovers New Drug Targets and Potential Therapies for Osteoarthritis
About one in five American adults have osteoarthritis, the most common form of arthritis, according to the Centers for Disease Control and Prevention. No treatment, however, exists to target the disease itself only to help patients manage symptoms like joint pain, stiffness and mobility issues. In an effort to learn more about the genetic underpinnings of the condition –which is expected to afflict 1 billion people worldwide by 2050 – a team of international researchers conducted the largest genome-wide association study ever performed on osteoarthritis.
Wednesday, April 09, 2025
Unite for Hope: Maryland Half Marathon & 5K Calls on Runners and Walkers to Fuel Cancer Research
Marking its 17th year, the Maryland Half Marathon & 5K returns to the Maple Lawn community in Howard County on Saturday, June 7, 2025. This signature event empowers runners, walkers, and fundraisers to join forces against cancer, driving critical support for the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC). Since 2009, the Maryland Half Marathon & 5K has raised over $6 million, fueling groundbreaking research and compassionate patient care.
Friday, April 04, 2025
Here’s to New Beginnings: UM School of Medicine Celebrates Match Day
Fourth-year medical students had a suspenseful day on Friday, March 21, as they gathered with family, faculty and staff to learn where they are headed off to residency in the annual ritual known as “Match Day”. Consistent with previous years, the 132 graduating seniors at the University of Maryland School of Medicine (UMSOM) had extremely high success with a 98 percent match rate.
Thursday, April 03, 2025
$12.75M MPower Grant to Spur Biomedical Tech Advances at 4MLK
A new five-year, $12.75 million grant from the University of Maryland Strategic Partnership: MPowering the State (MPower) aims to accelerate breakthroughs in biomedical technology and innovations through a collaboration between the University of Maryland, College Park (UMCP) and the University of Maryland, Baltimore (UMB).
Thursday, April 03, 2025
Researchers identify “master regulator” gene that could lead to more effective treatment for patients with ovarian cancer
In a study co-led by the University of Maryland School of Medicine (UMSOM), researchers have identified a “master regulator” gene, ZNFX1, that may act as a biomarker to help guide treatment in future clinical trials involving patients with therapy-resistant ovarian cancer, according to a study recently published in Cancer Research.
Wednesday, April 02, 2025
Researchers Reveal Key Brain Differences to Explain Why Ritalin Helps Improve Focus in Some More Than Others
Nearly 16 million American adults have been diagnosed with attention deficit hyperactivity disorder (ADHD), but evidence suggests that more than 30 percent of them don’t respond well to stimulant medications like Ritalin and Adderall. A new clinical trial provides a surprising explanation for why this may be the case: There are individual differences in how our brains circuits are wired, including the chemical circuits responsible for memory and concentration, according to a new study co-led by the University of Maryland School of Medicine (UMSOM) and performed at the National Institutes of Health (NIH) Clinical Center.
Tuesday, March 25, 2025
Internationally Recognized Vaccine Expert Dr. Paul Offit to Deliver Graduation Address to the University of Maryland School of Medicine’s 216th Graduating Class
Leading vaccine advocate Paul Offit, MD, an internationally recognized immunologist and virologist, will deliver the keynote address for this year’s graduating medical student class. He is best known as co-inventor of the rotavirus vaccine, RotaTeq, which is universally recommended for infants by the CDC and has been credited for saving hundreds of lives every day.
Monday, March 24, 2025
Susan Kinter Named as New President and CEO of the Maryland Medicine Comprehensive Insurance Program
Susan Kinter, BSN, JD, stepped into her new role at MMCIP on February 24 after serving in successive executive roles at the organization since 1998. In her new role, she will guide MMCIP in its core missions to ensure physician, staff, and patient safety across all the University of Maryland system member organizations and practice groups, as well as administering the Health Professional Liability Insurance Program for physicians and nurses.
Thursday, March 13, 2025
UMSOM Rising Third-Year Medical Students Celebrate Transition to Clinical Care Training at Annual Student Clinician Ceremony
The University of Maryland School of Medicine (UMSOM) celebrated 165 rising third-year medical students at the Annual Student Clinician Ceremony on March 4, as they prepare to begin their clinical care training. Over the next two years, students will transition from the classroom to the bedside to gain experience seeing patients through a wide variety of specialties within local healthcare organizations.
Wednesday, March 12, 2025
Meningococcal Vaccine Found to be Safe and Effective for Infants in Sub-Saharan Africa
University of Maryland School of Medicine (UMSOM) researchers helped conduct an important new global health study that found a vaccine that protects against five strains of meningitis prevalent in sub-Saharan Africa is safe and effective for use in young children beginning at 9 months of age. This study provided evidence that formed the basis for the World Health Organization’s (WHO) decision last year to recommend the pentavalent Men5CV meningitis vaccine for infants ages 9 months and older.